Passage Bio, Inc. (PASG)
NASDAQ: PASG · Real-Time Price · USD
0.525
-0.025 (-4.60%)
At close: Feb 21, 2025, 4:00 PM
0.522
-0.003 (-0.53%)
After-hours: Feb 21, 2025, 6:42 PM EST
Passage Bio Market Cap
Passage Bio has a market cap or net worth of $32.42 million as of February 21, 2025. Its market cap has decreased by -42.03% in one year.
Market Cap
32.42M
Enterprise Value
-26.59M
1-Year Change
-42.03%
Ranking
Category
Stock Price
$0.52
Market Cap Chart
Since February 28, 2020, Passage Bio's market cap has decreased from $956.75M to $32.42M, a decrease of -96.61%. That is a compound annual growth rate of -49.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 32.42M | -7.46% |
| Dec 31, 2024 | 35.03M | -36.74% |
| Dec 29, 2023 | 55.37M | -26.45% |
| Dec 30, 2022 | 75.28M | -78.09% |
| Dec 31, 2021 | 343.58M | -70.49% |
| Dec 31, 2020 | 1.16B | 21.70% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.76B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |